Suppr超能文献

印度德尔塔和奥密克戎变异株流行期间 SARS-CoV-2 的系统发育和进化。

Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India.

机构信息

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.

Central Core Research Facility, All India Institute of Medical Sciences, New Delhi, India.

出版信息

J Biomol Struct Dyn. 2024 Jun;42(9):4769-4781. doi: 10.1080/07391102.2023.2222832. Epub 2023 Jun 15.

Abstract

SARS-CoV-2 evolution has continued to generate variants, responsible for new pandemic waves locally and globally. Varying disease presentation and severity has been ascribed to inherent variant characteristics and vaccine immunity. This study analyzed genomic data from 305 whole genome sequences from SARS-CoV-2 patients before and through the third wave in India. Delta variant was reported in patients without comorbidity (97%), while Omicron BA.2 was reported in patients with comorbidity (77%). Tissue adaptation studies brought forth higher propensity of Omicron variants to bronchial tissue than lung, contrary to observation in Delta variants from Delhi. Study of codon usage pattern distinguished the prevalent variants, clustering them separately, Omicron BA.2 isolated in February grouped away from December strains, and all BA.2 after December acquired a new mutation S959P in ORF1b (44.3% of BA.2 in the study) indicating ongoing evolution. Loss of critical spike mutations in Omicron BA.2 and gain of immune evasion mutations including G142D, reported in Delta but absent in BA.1, and S371F instead of S371L in BA.1 could explain very brief period of BA.1 in December 2021, followed by complete replacement by BA.2. Higher propensity of Omicron variants to bronchial tissue, probably ensured increased transmission while Omicron BA.2 became the prevalent variant possibly due to evolutionary trade-off. Virus evolution continues to shape the epidemic and its culmination.Communicated by Ramaswamy H. Sarma.

摘要

SARS-CoV-2 的进化继续产生变种,导致当地和全球出现新的大流行浪潮。疾病表现和严重程度的变化归因于固有变种特征和疫苗免疫力。本研究分析了印度第三次浪潮之前和期间来自 305 例 SARS-CoV-2 患者的全基因组序列的基因组数据。无合并症的患者报告了 Delta 变异(97%),而合并症患者报告了 Omicron BA.2(77%)。组织适应研究表明,与观察到的德里的 Delta 变异相反,Omicron 变异对支气管组织的倾向性更高,而不是对肺组织。密码子使用模式的研究区分了流行变异,将它们分别聚类,2 月分离的 Omicron BA.2 与 12 月的菌株分开,12 月以后的所有 BA.2 都在 ORF1b 中获得了新的突变 S959P(研究中 BA.2 的 44.3%),表明正在进化。Omicron BA.2 中关键刺突突变的丢失和免疫逃逸突变的获得,包括 G142D,在 Delta 中报道,但在 BA.1 中不存在,而 BA.1 中的 S371F 而不是 S371L,可以解释 2021 年 12 月 BA.1 非常短暂的存在,随后被 BA.2 完全取代。Omicron 变异对支气管组织的更高倾向性可能确保了更高的传播性,而 Omicron BA.2 成为主要变异可能是由于进化权衡。病毒进化继续塑造着疫情及其结局。由 Ramaswamy H. Sarma 传达。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验